The London Stock Exchange uses cookies to improve its website. The cookies for analytical purposes have already been set. For more details and how to manage cookies, please see our privacy and cookies policy.


GWP GW PHARMACEUTICALS PLC ORD 0.1P

GW PHARM.  Currency  GBX 



 Page 2 of 4

Previous | 1 | 2 | 3 | 4 | Next

Time/Date Code Headline Source Impact
07:00 07-May-2014 GWP IND for Epidiolex Ph 2/3 Trial in Dravet Syndrome RNS -5.21% Down
17:54 06-May-2014 GWP Holding(s) in Company RNS -4.73% Down
07:01 06-May-2014 GWP Appointment of VP, Clinical Science RNS -4.73% Down
17:30 29-Apr-2014 GWP Notice of Results RNS +7.64% Up
13:46 28-Apr-2014 GWP Holding(s) in Company RNS +7.60% Up
07:00 28-Apr-2014 GWP Sativex FDA Fast Track Designation in Cancer Pain RNS +7.60% Up
15:24 19-Mar-2014 GWP Holding(s) in Company RNS -13.03% Down
07:00 17-Mar-2014 GWP Update on Cannabinoid Pipeline RNS -12.48% Down
14:34 11-Mar-2014 GWP Annual General Meeting RNS +3.88% Up
13:00 28-Feb-2014 GWP FDA Orphan Drug Designation received for Epidiolex RNS +13.24% Up
07:00 27-Feb-2014 GWP GW to Present at Cowen Health Care Conference RNS +16.38% Up
10:20 18-Feb-2014 GWP Blocklisting Interim Review RNS -4.50% Down
13:47 12-Feb-2014 GWP Additional Listing RNS -4.06% Down
17:00 10-Feb-2014 GWP Presenting at Leerink Global Healthcare Conference RNS +2.80% Up
07:00 05-Feb-2014 GWP Q1 2014 Financial Results and Operational Progress RNS +10.02% Up
15:17 31-Jan-2014 GWP Holding(s) in Company RNS +18.04% Up
07:00 29-Jan-2014 GWP Notice of Results RNS +18.87% Up
17:11 17-Jan-2014 GWP Holding(s) in Company RNS -2.07% Down
11:13 16-Jan-2014 GWP Additional Listing RNS -1.86% Down
16:34 15-Jan-2014 GWP Holding(s) in Company RNS +0.41% Up

 Page 2 of 4

Previous | 1 | 2 | 3 | 4 | Next

Price changes are calculated on the basis of the following formula: [ avg(x) - avg(y)] / avg(y) where:
x = instrument's 7 closing prices after the news has been released, including the day of the release of the news
y = instrument's latest 7 closing prices before the news was released

Please note that the news releases are only one of the multiple factors that could have had an impact on the change in the security’s price over the time period analysed by the News Analysis tool. Where data are insufficient the graph does not show any price change and the table below the graph displays a blank " - " next to the line indicating the RNS issue.


GW PHARM. share - news analysis

The Exchange accepts no responsibility for the content of the website you are now accessing or for any reliance placed by you or any person on the information contained on it.

By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.

You will be redirected in five seconds.

You are accessing the London Stock Exchange Annual Report Service powered by PrecisionIR.

The Exchange accepts no responsibility for the content of the reports you are now accessing or for any reliance placed by you or any person on the information contained therein.

By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.

You will be redirected in five seconds